Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hantavirus Infections | 33 | 2023 | 34 | 10.980 |
Why?
|
Shrews | 23 | 2023 | 25 | 9.050 |
Why?
|
Phylogeny | 74 | 2023 | 612 | 7.850 |
Why?
|
Genetic Variation | 31 | 2021 | 328 | 5.360 |
Why?
|
Moles | 10 | 2023 | 10 | 5.340 |
Why?
|
RNA, Viral | 28 | 2023 | 287 | 3.280 |
Why?
|
Chiroptera | 9 | 2020 | 20 | 3.060 |
Why?
|
Evolution, Molecular | 14 | 2022 | 249 | 2.410 |
Why?
|
Animals | 142 | 2023 | 14307 | 2.170 |
Why?
|
Human T-lymphotropic virus 1 | 25 | 1999 | 33 | 2.110 |
Why?
|
Arvicolinae | 18 | 2021 | 19 | 2.090 |
Why?
|
Disease Reservoirs | 12 | 2019 | 20 | 1.780 |
Why?
|
Genome, Viral | 16 | 2022 | 103 | 1.750 |
Why?
|
HTLV-I Infections | 22 | 1995 | 31 | 1.570 |
Why?
|
Molecular Sequence Data | 54 | 2014 | 1490 | 1.430 |
Why?
|
Minority Groups | 7 | 2023 | 537 | 1.290 |
Why?
|
Sequence Analysis, DNA | 22 | 2019 | 455 | 1.230 |
Why?
|
Rodent Diseases | 5 | 2014 | 8 | 1.140 |
Why?
|
Bayes Theorem | 7 | 2023 | 91 | 1.120 |
Why?
|
Biomedical Research | 5 | 2023 | 371 | 1.050 |
Why?
|
Genes, Viral | 14 | 2016 | 62 | 1.030 |
Why?
|
Hemorrhagic Fever with Renal Syndrome | 20 | 2015 | 21 | 0.990 |
Why?
|
Base Sequence | 35 | 2013 | 932 | 0.970 |
Why?
|
Papilloma | 5 | 2001 | 15 | 0.940 |
Why?
|
Polymerase Chain Reaction | 31 | 2002 | 430 | 0.940 |
Why?
|
DNA, Viral | 27 | 2007 | 295 | 0.920 |
Why?
|
Genotype | 12 | 2015 | 641 | 0.900 |
Why?
|
Herpesviridae Infections | 6 | 2003 | 18 | 0.880 |
Why?
|
Puumala virus | 3 | 2021 | 3 | 0.870 |
Why?
|
Turtles | 6 | 2003 | 28 | 0.870 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 14 | 2020 | 605 | 0.830 |
Why?
|
Humans | 163 | 2023 | 34853 | 0.830 |
Why?
|
Vietnam | 9 | 2021 | 38 | 0.780 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 17 | 0.770 |
Why?
|
Peromyscus | 8 | 1996 | 11 | 0.750 |
Why?
|
Lung | 19 | 2019 | 413 | 0.740 |
Why?
|
Russia | 4 | 2022 | 24 | 0.740 |
Why?
|
Cell Line | 21 | 2014 | 1289 | 0.740 |
Why?
|
Poland | 6 | 2023 | 7 | 0.740 |
Why?
|
Antibodies, Viral | 26 | 2009 | 252 | 0.700 |
Why?
|
Amino Acid Sequence | 24 | 2013 | 1124 | 0.660 |
Why?
|
Paraparesis, Tropical Spastic | 9 | 2001 | 12 | 0.660 |
Why?
|
HIV-1 | 10 | 2010 | 678 | 0.630 |
Why?
|
Disaster Planning | 1 | 2018 | 51 | 0.630 |
Why?
|
Creutzfeldt-Jakob Syndrome | 22 | 1997 | 28 | 0.620 |
Why?
|
Disasters | 1 | 2018 | 64 | 0.610 |
Why?
|
Cyclonic Storms | 1 | 2018 | 62 | 0.610 |
Why?
|
JC Virus | 9 | 2007 | 24 | 0.610 |
Why?
|
RNA Viruses | 11 | 2019 | 22 | 0.600 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 11 | 0.600 |
Why?
|
Hotlines | 1 | 2017 | 14 | 0.600 |
Why?
|
Geography | 6 | 2021 | 86 | 0.570 |
Why?
|
Hepatitis, Viral, Human | 4 | 2000 | 12 | 0.560 |
Why?
|
Sequence Analysis, RNA | 2 | 2016 | 104 | 0.550 |
Why?
|
Universities | 1 | 2018 | 363 | 0.530 |
Why?
|
Cluster Analysis | 7 | 2014 | 188 | 0.510 |
Why?
|
DNA Virus Infections | 5 | 2002 | 16 | 0.500 |
Why?
|
Skin Neoplasms | 3 | 2001 | 151 | 0.490 |
Why?
|
HIV Infections | 9 | 2010 | 2207 | 0.490 |
Why?
|
Research | 3 | 2021 | 159 | 0.480 |
Why?
|
Gene Products, env | 9 | 1994 | 23 | 0.470 |
Why?
|
Melanesia | 20 | 2005 | 22 | 0.440 |
Why?
|
Prevalence | 10 | 2015 | 1425 | 0.430 |
Why?
|
Seals, Earless | 2 | 2003 | 6 | 0.430 |
Why?
|
Male | 74 | 2023 | 18870 | 0.430 |
Why?
|
Amyotrophic Lateral Sclerosis | 19 | 1998 | 45 | 0.430 |
Why?
|
Herpesviridae | 2 | 2003 | 13 | 0.420 |
Why?
|
Viruses | 2 | 2003 | 35 | 0.420 |
Why?
|
Health Services Research | 2 | 2010 | 133 | 0.410 |
Why?
|
Female | 65 | 2023 | 19873 | 0.400 |
Why?
|
Flaviviridae | 3 | 2000 | 4 | 0.390 |
Why?
|
Alphaherpesvirinae | 2 | 2001 | 2 | 0.390 |
Why?
|
Genes, env | 8 | 1996 | 13 | 0.390 |
Why?
|
DNA Primers | 9 | 2021 | 269 | 0.380 |
Why?
|
Reassortant Viruses | 2 | 2020 | 10 | 0.370 |
Why?
|
Emigration and Immigration | 3 | 2002 | 72 | 0.370 |
Why?
|
Japan | 6 | 2021 | 296 | 0.360 |
Why?
|
DNA, Mitochondrial | 5 | 2011 | 165 | 0.360 |
Why?
|
Guam | 19 | 2023 | 76 | 0.360 |
Why?
|
Simian T-lymphotropic virus 1 | 5 | 1995 | 6 | 0.350 |
Why?
|
Research Personnel | 4 | 2022 | 133 | 0.350 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 4 | 2003 | 23 | 0.350 |
Why?
|
Genetics, Population | 5 | 2005 | 66 | 0.350 |
Why?
|
Rodentia | 6 | 2021 | 41 | 0.350 |
Why?
|
Education, Public Health Professional | 1 | 2009 | 18 | 0.350 |
Why?
|
Mice | 32 | 2021 | 5668 | 0.340 |
Why?
|
Cote d'Ivoire | 3 | 2014 | 6 | 0.340 |
Why?
|
Siberia | 3 | 2015 | 4 | 0.330 |
Why?
|
Adult | 44 | 2023 | 11034 | 0.330 |
Why?
|
Receptors, CCR5 | 2 | 1999 | 59 | 0.330 |
Why?
|
Murinae | 3 | 2021 | 4 | 0.330 |
Why?
|
Host-Pathogen Interactions | 4 | 2018 | 179 | 0.320 |
Why?
|
Sequence Deletion | 2 | 1999 | 87 | 0.320 |
Why?
|
Parkinson Disease | 17 | 1998 | 167 | 0.320 |
Why?
|
West Nile virus | 4 | 2014 | 65 | 0.320 |
Why?
|
Dementia | 15 | 1998 | 133 | 0.320 |
Why?
|
Virus Replication | 11 | 2014 | 261 | 0.320 |
Why?
|
Torque teno virus | 3 | 2002 | 10 | 0.320 |
Why?
|
Florida | 2 | 2020 | 358 | 0.320 |
Why?
|
Sequence Homology, Amino Acid | 10 | 2009 | 249 | 0.320 |
Why?
|
Neurodegenerative Diseases | 2 | 2009 | 119 | 0.320 |
Why?
|
United States | 13 | 2022 | 3894 | 0.310 |
Why?
|
Brain | 23 | 2015 | 1268 | 0.310 |
Why?
|
Environmental Exposure | 2 | 2009 | 207 | 0.300 |
Why?
|
Immunoglobulin G | 6 | 1998 | 232 | 0.300 |
Why?
|
Scrapie | 12 | 1993 | 14 | 0.300 |
Why?
|
Sequence Homology, Nucleic Acid | 12 | 2008 | 84 | 0.300 |
Why?
|
North America | 2 | 2019 | 60 | 0.300 |
Why?
|
Middle Aged | 52 | 2020 | 9642 | 0.300 |
Why?
|
HIV Seropositivity | 2 | 1998 | 182 | 0.280 |
Why?
|
Hungary | 2 | 2019 | 9 | 0.280 |
Why?
|
Mental Health | 1 | 2009 | 270 | 0.270 |
Why?
|
Viral Proteins | 10 | 2011 | 172 | 0.270 |
Why?
|
Blood Donors | 2 | 1998 | 17 | 0.270 |
Why?
|
Mental Disorders | 1 | 2009 | 285 | 0.270 |
Why?
|
China | 4 | 2020 | 178 | 0.270 |
Why?
|
Papua New Guinea | 13 | 2001 | 20 | 0.260 |
Why?
|
Viruses, Unclassified | 2 | 2021 | 3 | 0.260 |
Why?
|
Pacific Islands | 6 | 2009 | 115 | 0.250 |
Why?
|
Africa | 6 | 2020 | 62 | 0.250 |
Why?
|
Immunity, Innate | 4 | 2014 | 135 | 0.250 |
Why?
|
HTLV-I Antibodies | 6 | 1994 | 7 | 0.250 |
Why?
|
Hantaan virus | 4 | 2013 | 4 | 0.250 |
Why?
|
Texas | 3 | 2018 | 299 | 0.250 |
Why?
|
Gene Expression Regulation, Viral | 2 | 2014 | 108 | 0.250 |
Why?
|
Maryland | 2 | 2021 | 53 | 0.250 |
Why?
|
Spain | 2 | 2023 | 33 | 0.250 |
Why?
|
Retroviridae Proteins, Oncogenic | 6 | 1994 | 27 | 0.250 |
Why?
|
Fluorescent Antibody Technique | 18 | 1991 | 185 | 0.240 |
Why?
|
DNA-Directed RNA Polymerases | 1 | 2003 | 25 | 0.230 |
Why?
|
Ukraine | 1 | 2023 | 3 | 0.230 |
Why?
|
RNA-Directed DNA Polymerase | 3 | 2001 | 17 | 0.230 |
Why?
|
Antigens, Viral | 9 | 2009 | 42 | 0.230 |
Why?
|
Leukocytes, Mononuclear | 3 | 2002 | 224 | 0.230 |
Why?
|
Microscopy, Electron | 19 | 2000 | 186 | 0.220 |
Why?
|
Sequence Homology | 4 | 2014 | 34 | 0.220 |
Why?
|
Substance Abuse, Intravenous | 3 | 1999 | 123 | 0.220 |
Why?
|
Aluminum | 8 | 1991 | 34 | 0.220 |
Why?
|
Minority Health | 2 | 2022 | 81 | 0.220 |
Why?
|
Endothelial Cells | 4 | 2013 | 296 | 0.220 |
Why?
|
Hantavirus | 1 | 2002 | 1 | 0.220 |
Why?
|
Hawaii | 4 | 2023 | 1878 | 0.220 |
Why?
|
Antigens, CD19 | 1 | 2002 | 13 | 0.210 |
Why?
|
Vero Cells | 7 | 2015 | 90 | 0.210 |
Why?
|
Virus Integration | 1 | 2002 | 49 | 0.210 |
Why?
|
Madagascar | 1 | 2021 | 7 | 0.210 |
Why?
|
Prions | 10 | 1997 | 25 | 0.210 |
Why?
|
Epitopes | 6 | 1995 | 145 | 0.200 |
Why?
|
Chromosome Walking | 1 | 2001 | 2 | 0.200 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2021 | 14 | 0.200 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2021 | 28 | 0.200 |
Why?
|
Coronavirus | 1 | 2020 | 7 | 0.200 |
Why?
|
Polymorphism, Genetic | 4 | 2007 | 165 | 0.200 |
Why?
|
Virginia | 1 | 2020 | 9 | 0.200 |
Why?
|
Asia | 3 | 2014 | 74 | 0.190 |
Why?
|
Animal Diseases | 2 | 2000 | 5 | 0.190 |
Why?
|
Hepatitis C | 2 | 1999 | 120 | 0.190 |
Why?
|
Neutralization Tests | 8 | 2009 | 53 | 0.190 |
Why?
|
Rats | 11 | 2021 | 3261 | 0.190 |
Why?
|
HTLV-II Infections | 4 | 1993 | 6 | 0.190 |
Why?
|
Viral Envelope Proteins | 7 | 2004 | 77 | 0.190 |
Why?
|
Herpesvirus 1, Cercopithecine | 1 | 2000 | 3 | 0.190 |
Why?
|
Myanmar | 1 | 2019 | 1 | 0.180 |
Why?
|
Animals, Wild | 3 | 2020 | 15 | 0.180 |
Why?
|
Macrophages | 6 | 2013 | 431 | 0.180 |
Why?
|
Blotting, Western | 13 | 2014 | 834 | 0.180 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 1998 | 41 | 0.170 |
Why?
|
Neurons | 12 | 2014 | 1130 | 0.170 |
Why?
|
New Orleans | 1 | 2018 | 11 | 0.170 |
Why?
|
Korea | 5 | 2014 | 43 | 0.170 |
Why?
|
Motor Neurons | 3 | 1991 | 72 | 0.170 |
Why?
|
Behavioral Research | 1 | 2019 | 37 | 0.170 |
Why?
|
Genetic Vectors | 3 | 2008 | 154 | 0.170 |
Why?
|
Hantavirus Pulmonary Syndrome | 2 | 1995 | 3 | 0.170 |
Why?
|
Genes, nef | 1 | 1998 | 5 | 0.160 |
Why?
|
Astrocytes | 6 | 2014 | 203 | 0.160 |
Why?
|
Europe | 3 | 2018 | 88 | 0.160 |
Why?
|
Gene Products, nef | 1 | 1998 | 19 | 0.160 |
Why?
|
Leukemia, T-Cell | 2 | 1995 | 5 | 0.160 |
Why?
|
Sequence Alignment | 6 | 2010 | 257 | 0.160 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2003 | 325 | 0.160 |
Why?
|
Primates | 2 | 1995 | 36 | 0.160 |
Why?
|
Sensitivity and Specificity | 7 | 2021 | 555 | 0.160 |
Why?
|
Bunyaviridae | 3 | 1987 | 4 | 0.160 |
Why?
|
Infant | 8 | 2002 | 1014 | 0.160 |
Why?
|
Puerto Rico | 3 | 2018 | 1352 | 0.160 |
Why?
|
Hospitalization | 1 | 2020 | 370 | 0.150 |
Why?
|
Nepal | 2 | 2020 | 14 | 0.150 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 8 | 2003 | 445 | 0.150 |
Why?
|
Child, Preschool | 9 | 2002 | 1318 | 0.150 |
Why?
|
Pacific Ocean | 1 | 2017 | 13 | 0.150 |
Why?
|
Biological Specimen Banks | 1 | 2017 | 21 | 0.150 |
Why?
|
Cells, Cultured | 13 | 2012 | 1442 | 0.150 |
Why?
|
Tissue Distribution | 3 | 2014 | 197 | 0.150 |
Why?
|
Leukemia-Lymphoma, Adult T-Cell | 2 | 1994 | 8 | 0.150 |
Why?
|
Sulfonamides | 3 | 1993 | 75 | 0.150 |
Why?
|
Child | 12 | 2003 | 2875 | 0.140 |
Why?
|
Taiwan | 1 | 2016 | 11 | 0.140 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 592 | 0.140 |
Why?
|
Likelihood Functions | 1 | 2016 | 59 | 0.140 |
Why?
|
Axons | 7 | 1999 | 106 | 0.140 |
Why?
|
Deltaretrovirus Antibodies | 3 | 1992 | 3 | 0.140 |
Why?
|
Gene Products, gag | 2 | 1994 | 12 | 0.140 |
Why?
|
Species Specificity | 9 | 2006 | 233 | 0.140 |
Why?
|
Databases, Factual | 1 | 2017 | 288 | 0.140 |
Why?
|
Nervous System Diseases | 6 | 1991 | 66 | 0.140 |
Why?
|
Oligodeoxyribonucleotides | 2 | 1992 | 52 | 0.130 |
Why?
|
Mentors | 2 | 2023 | 111 | 0.130 |
Why?
|
Jews | 1 | 1995 | 4 | 0.130 |
Why?
|
Hominidae | 2 | 1995 | 11 | 0.130 |
Why?
|
Virulence | 4 | 2007 | 221 | 0.130 |
Why?
|
Endoplasmic Reticulum | 2 | 2014 | 101 | 0.130 |
Why?
|
Cytopathogenic Effect, Viral | 5 | 2008 | 13 | 0.130 |
Why?
|
Plasticizers | 3 | 1993 | 7 | 0.130 |
Why?
|
Adolescent | 11 | 1999 | 5035 | 0.130 |
Why?
|
Spinal Cord | 6 | 2001 | 85 | 0.130 |
Why?
|
Kuru | 4 | 1996 | 4 | 0.130 |
Why?
|
Nerve Degeneration | 4 | 1992 | 101 | 0.120 |
Why?
|
Glycosaminoglycans | 2 | 1991 | 22 | 0.120 |
Why?
|
Africa South of the Sahara | 1 | 2014 | 43 | 0.120 |
Why?
|
Sigmodontinae | 1 | 2014 | 1 | 0.120 |
Why?
|
Age Factors | 8 | 2015 | 1007 | 0.120 |
Why?
|
HTLV-I Antigens | 1 | 1993 | 1 | 0.120 |
Why?
|
Health Services Accessibility | 1 | 2018 | 531 | 0.120 |
Why?
|
Inclusion Bodies, Viral | 3 | 1991 | 4 | 0.120 |
Why?
|
Viremia | 2 | 1999 | 40 | 0.120 |
Why?
|
Intercostal Muscles | 1 | 2013 | 1 | 0.120 |
Why?
|
France | 1 | 2013 | 17 | 0.120 |
Why?
|
Guinea | 1 | 2013 | 3 | 0.120 |
Why?
|
India | 4 | 2020 | 82 | 0.120 |
Why?
|
Viral Nonstructural Proteins | 1 | 2014 | 45 | 0.120 |
Why?
|
Neoplasms | 1 | 2003 | 1033 | 0.120 |
Why?
|
History, 20th Century | 2 | 2009 | 110 | 0.110 |
Why?
|
Heterozygote | 3 | 1999 | 91 | 0.110 |
Why?
|
Deltaretrovirus Antigens | 2 | 1992 | 2 | 0.110 |
Why?
|
Protein Structure, Secondary | 2 | 2009 | 172 | 0.110 |
Why?
|
Gene Expression Regulation | 3 | 2013 | 968 | 0.110 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2004 | 219 | 0.110 |
Why?
|
Disease Models, Animal | 12 | 1999 | 1300 | 0.110 |
Why?
|
Cross-Cultural Comparison | 1 | 1992 | 100 | 0.110 |
Why?
|
Cricetinae | 10 | 2015 | 217 | 0.110 |
Why?
|
Occupational Diseases | 3 | 1996 | 45 | 0.110 |
Why?
|
Muscle Spasticity | 2 | 1991 | 2 | 0.110 |
Why?
|
Calcium | 6 | 1986 | 445 | 0.100 |
Why?
|
Brain Chemistry | 2 | 1991 | 134 | 0.100 |
Why?
|
Genes, gag | 4 | 1995 | 5 | 0.100 |
Why?
|
Genes, pol | 4 | 1995 | 15 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 2 | 2009 | 528 | 0.100 |
Why?
|
Nucleocapsid | 2 | 2004 | 12 | 0.100 |
Why?
|
Aged | 20 | 2020 | 6448 | 0.100 |
Why?
|
Myelin Sheath | 8 | 1999 | 42 | 0.100 |
Why?
|
Dementia, Vascular | 1 | 1991 | 34 | 0.100 |
Why?
|
Sequence Analysis | 2 | 2008 | 24 | 0.100 |
Why?
|
Capsid Proteins | 2 | 2001 | 60 | 0.100 |
Why?
|
Gene Amplification | 3 | 1996 | 24 | 0.100 |
Why?
|
Liver | 2 | 2015 | 447 | 0.090 |
Why?
|
Bunyaviridae Infections | 2 | 1993 | 5 | 0.090 |
Why?
|
Founder Effect | 1 | 2010 | 7 | 0.090 |
Why?
|
Finland | 1 | 2009 | 10 | 0.090 |
Why?
|
Demography | 1 | 2010 | 167 | 0.090 |
Why?
|
Transduction, Genetic | 2 | 2008 | 19 | 0.090 |
Why?
|
Drug Users | 1 | 2010 | 42 | 0.090 |
Why?
|
Oregon | 1 | 2009 | 39 | 0.090 |
Why?
|
Aged, 80 and over | 8 | 2020 | 2333 | 0.090 |
Why?
|
Australia | 4 | 2005 | 76 | 0.090 |
Why?
|
Glial Fibrillary Acidic Protein | 4 | 1997 | 63 | 0.090 |
Why?
|
Serotyping | 4 | 1994 | 36 | 0.090 |
Why?
|
RNA, Messenger | 4 | 2008 | 1152 | 0.090 |
Why?
|
Muridae | 5 | 2000 | 5 | 0.090 |
Why?
|
Acquired Immunodeficiency Syndrome | 3 | 2004 | 214 | 0.080 |
Why?
|
Mesocricetus | 9 | 2015 | 53 | 0.080 |
Why?
|
Seasons | 1 | 2009 | 112 | 0.080 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2009 | 143 | 0.080 |
Why?
|
Adenoviridae | 1 | 2008 | 59 | 0.080 |
Why?
|
Health Status Disparities | 2 | 2019 | 583 | 0.080 |
Why?
|
Amino Acid Motifs | 1 | 2008 | 85 | 0.080 |
Why?
|
Encephalopathy, Bovine Spongiform | 3 | 1993 | 3 | 0.080 |
Why?
|
Moloney murine leukemia virus | 1 | 2008 | 7 | 0.080 |
Why?
|
Hepacivirus | 2 | 1999 | 59 | 0.080 |
Why?
|
MicroRNAs | 1 | 2013 | 386 | 0.080 |
Why?
|
Metacarpus | 3 | 1989 | 4 | 0.080 |
Why?
|
Recombination, Genetic | 1 | 2008 | 90 | 0.080 |
Why?
|
Selenium | 2 | 2008 | 144 | 0.080 |
Why?
|
Republic of Korea | 3 | 2013 | 103 | 0.080 |
Why?
|
Proteinuria | 1 | 1988 | 48 | 0.080 |
Why?
|
Mutation | 4 | 2000 | 1023 | 0.080 |
Why?
|
Immunohistochemistry | 7 | 1996 | 859 | 0.080 |
Why?
|
Infant, Newborn | 4 | 2000 | 871 | 0.080 |
Why?
|
Bone and Bones | 2 | 1989 | 89 | 0.080 |
Why?
|
Deer | 3 | 1993 | 11 | 0.080 |
Why?
|
Templates, Genetic | 2 | 2001 | 22 | 0.080 |
Why?
|
West Nile Fever | 1 | 2008 | 56 | 0.080 |
Why?
|
Molecular Epidemiology | 2 | 2020 | 49 | 0.080 |
Why?
|
Gerstmann-Straussler-Scheinker Disease | 3 | 1996 | 3 | 0.080 |
Why?
|
Receptor, Serotonin, 5-HT2A | 1 | 2007 | 16 | 0.080 |
Why?
|
Gene Expression Profiling | 2 | 2013 | 600 | 0.080 |
Why?
|
Risk Factors | 4 | 2020 | 3414 | 0.070 |
Why?
|
Neurofibrils | 6 | 1999 | 23 | 0.070 |
Why?
|
T-Lymphocytes | 5 | 1995 | 341 | 0.070 |
Why?
|
Antiviral Agents | 1 | 2008 | 148 | 0.070 |
Why?
|
Meningoencephalitis | 4 | 2015 | 13 | 0.070 |
Why?
|
Pakistan | 2 | 2020 | 21 | 0.070 |
Why?
|
Defective Viruses | 1 | 2006 | 10 | 0.070 |
Why?
|
Lentivirus | 1 | 2006 | 20 | 0.070 |
Why?
|
Alzheimer Disease | 5 | 1998 | 881 | 0.070 |
Why?
|
RNA, Small Interfering | 1 | 2008 | 391 | 0.070 |
Why?
|
Interferons | 1 | 2005 | 34 | 0.070 |
Why?
|
Escherichia coli | 2 | 2008 | 436 | 0.070 |
Why?
|
DNA, Complementary | 3 | 2007 | 175 | 0.070 |
Why?
|
Cross Reactions | 5 | 2006 | 83 | 0.070 |
Why?
|
Yugoslavia | 3 | 2002 | 3 | 0.070 |
Why?
|
Risk-Taking | 2 | 1999 | 435 | 0.070 |
Why?
|
Healthcare Disparities | 1 | 2010 | 446 | 0.070 |
Why?
|
Cell Line, Tumor | 5 | 2014 | 2128 | 0.070 |
Why?
|
Zoonoses | 3 | 1995 | 19 | 0.070 |
Why?
|
Genes, pX | 2 | 1995 | 3 | 0.070 |
Why?
|
Tumor Cells, Cultured | 4 | 2000 | 480 | 0.060 |
Why?
|
Viral Structural Proteins | 2 | 1995 | 16 | 0.060 |
Why?
|
HIV Seroprevalence | 2 | 1996 | 11 | 0.060 |
Why?
|
Culicidae | 1 | 2004 | 21 | 0.060 |
Why?
|
New Guinea | 3 | 2005 | 5 | 0.060 |
Why?
|
Microscopy, Phase-Contrast | 1 | 2003 | 9 | 0.060 |
Why?
|
Acidosis, Lactic | 1 | 2003 | 4 | 0.060 |
Why?
|
Monocyte Chemoattractant Proteins | 1 | 2003 | 1 | 0.060 |
Why?
|
Salicylic Acid | 1 | 2003 | 6 | 0.060 |
Why?
|
Hippocampus | 6 | 1998 | 546 | 0.060 |
Why?
|
Calcitriol | 1 | 1984 | 30 | 0.060 |
Why?
|
Leukoencephalopathy, Progressive Multifocal | 2 | 2007 | 7 | 0.060 |
Why?
|
Pan troglodytes | 5 | 1988 | 21 | 0.060 |
Why?
|
Neurotoxins | 2 | 1994 | 52 | 0.060 |
Why?
|
Cloning, Molecular | 3 | 2000 | 310 | 0.060 |
Why?
|
Indians, South American | 2 | 1993 | 5 | 0.060 |
Why?
|
Capsid | 2 | 2001 | 51 | 0.060 |
Why?
|
Tumor Virus Infections | 1 | 2003 | 25 | 0.060 |
Why?
|
Prion Diseases | 2 | 1993 | 9 | 0.060 |
Why?
|
Cell Adhesion Molecules | 1 | 2003 | 70 | 0.060 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2003 | 14 | 0.060 |
Why?
|
Genes | 2 | 2001 | 58 | 0.060 |
Why?
|
Coronary Vessels | 1 | 2003 | 93 | 0.060 |
Why?
|
Proteins | 1 | 2005 | 352 | 0.060 |
Why?
|
Chromosome Mapping | 3 | 1999 | 159 | 0.060 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2004 | 251 | 0.060 |
Why?
|
Ganglia, Spinal | 2 | 2001 | 36 | 0.060 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2022 | 77 | 0.060 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2002 | 37 | 0.060 |
Why?
|
Immunoenzyme Techniques | 5 | 1998 | 105 | 0.050 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2003 | 88 | 0.050 |
Why?
|
Phenotype | 2 | 1997 | 650 | 0.050 |
Why?
|
Cattle Diseases | 2 | 1992 | 21 | 0.050 |
Why?
|
Neuromuscular Diseases | 1 | 1982 | 5 | 0.050 |
Why?
|
Seroepidemiologic Studies | 2 | 2000 | 67 | 0.050 |
Why?
|
DNA Topoisomerase IV | 1 | 2001 | 2 | 0.050 |
Why?
|
DNA Gyrase | 1 | 2001 | 7 | 0.050 |
Why?
|
Ofloxacin | 1 | 2001 | 6 | 0.050 |
Why?
|
Program Development | 1 | 2023 | 225 | 0.050 |
Why?
|
Respirovirus | 2 | 1980 | 2 | 0.050 |
Why?
|
Minerals | 1 | 1982 | 45 | 0.050 |
Why?
|
Amyloid | 2 | 1993 | 52 | 0.050 |
Why?
|
Streptococcus pneumoniae | 1 | 2001 | 28 | 0.050 |
Why?
|
Restriction Mapping | 2 | 1991 | 42 | 0.050 |
Why?
|
Feces | 2 | 2000 | 110 | 0.050 |
Why?
|
Nucleocapsid Proteins | 1 | 2021 | 9 | 0.050 |
Why?
|
Reverse Transcription | 1 | 2021 | 16 | 0.050 |
Why?
|
DNA Restriction Enzymes | 1 | 2001 | 14 | 0.050 |
Why?
|
Metals | 1 | 1982 | 95 | 0.050 |
Why?
|
Clinical Laboratory Techniques | 1 | 2021 | 22 | 0.050 |
Why?
|
Drug Resistance, Bacterial | 1 | 2001 | 78 | 0.050 |
Why?
|
Parainfluenza Virus 1, Human | 1 | 1980 | 1 | 0.050 |
Why?
|
Parainfluenza Virus 2, Human | 1 | 1980 | 1 | 0.050 |
Why?
|
Paramyxoviridae Infections | 1 | 1980 | 1 | 0.050 |
Why?
|
Anti-Infective Agents | 1 | 2001 | 62 | 0.050 |
Why?
|
New York | 3 | 1995 | 69 | 0.050 |
Why?
|
Hypnotics and Sedatives | 1 | 2020 | 27 | 0.050 |
Why?
|
Immunoglobulin A, Secretory | 1 | 1980 | 16 | 0.050 |
Why?
|
Lymphatic Diseases | 1 | 1980 | 7 | 0.050 |
Why?
|
Immunoglobulin A | 1 | 1980 | 58 | 0.050 |
Why?
|
Parvoviridae Infections | 1 | 2000 | 1 | 0.050 |
Why?
|
Parvovirus B19, Human | 1 | 2000 | 1 | 0.050 |
Why?
|
Pilot Projects | 1 | 2023 | 628 | 0.050 |
Why?
|
Muscle, Skeletal | 2 | 2001 | 257 | 0.050 |
Why?
|
Chlamydophila pneumoniae | 1 | 2000 | 8 | 0.050 |
Why?
|
Cell Aggregation | 1 | 2000 | 14 | 0.050 |
Why?
|
Nerve Tissue Proteins | 3 | 1993 | 338 | 0.050 |
Why?
|
Belgium | 1 | 2020 | 4 | 0.050 |
Why?
|
Chi-Square Distribution | 1 | 2020 | 213 | 0.050 |
Why?
|
Herpesvirus 8, Human | 1 | 2000 | 25 | 0.050 |
Why?
|
Neurites | 3 | 1995 | 35 | 0.050 |
Why?
|
Incidence | 4 | 2002 | 882 | 0.050 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2000 | 18 | 0.050 |
Why?
|
Karyotyping | 1 | 2000 | 46 | 0.050 |
Why?
|
Congresses as Topic | 1 | 2020 | 38 | 0.050 |
Why?
|
Cryopreservation | 1 | 2000 | 24 | 0.050 |
Why?
|
Sex Factors | 4 | 1991 | 859 | 0.050 |
Why?
|
Neurofilament Proteins | 3 | 1995 | 27 | 0.050 |
Why?
|
Influenza A virus | 2 | 1999 | 25 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2021 | 63 | 0.040 |
Why?
|
Diagnosis, Differential | 3 | 1998 | 211 | 0.040 |
Why?
|
Borna disease virus | 1 | 1999 | 1 | 0.040 |
Why?
|
Rabbits | 4 | 1994 | 278 | 0.040 |
Why?
|
Cell Survival | 2 | 2000 | 818 | 0.040 |
Why?
|
Neurofibrillary Tangles | 3 | 1998 | 112 | 0.040 |
Why?
|
Frontal Lobe | 1 | 1999 | 49 | 0.040 |
Why?
|
Hepatitis Viruses | 1 | 1999 | 3 | 0.040 |
Why?
|
DNA Viruses | 1 | 1999 | 14 | 0.040 |
Why?
|
Serologic Tests | 2 | 2006 | 43 | 0.040 |
Why?
|
Research Support as Topic | 1 | 2019 | 75 | 0.040 |
Why?
|
Alanine Transaminase | 1 | 1998 | 26 | 0.040 |
Why?
|
Bipolar Disorder | 1 | 1999 | 46 | 0.040 |
Why?
|
Sexually Transmitted Diseases, Viral | 1 | 1998 | 11 | 0.040 |
Why?
|
Surface-Active Agents | 1 | 1999 | 41 | 0.040 |
Why?
|
New England | 2 | 1995 | 16 | 0.040 |
Why?
|
Schizophrenia | 1 | 1999 | 73 | 0.040 |
Why?
|
Gene Frequency | 1 | 1999 | 155 | 0.040 |
Why?
|
Deltaretrovirus Infections | 2 | 1995 | 2 | 0.040 |
Why?
|
Proviruses | 2 | 1995 | 27 | 0.040 |
Why?
|
Toxoplasmosis, Cerebral | 1 | 1998 | 9 | 0.040 |
Why?
|
Blotting, Southern | 2 | 2002 | 66 | 0.040 |
Why?
|
Transcription, Genetic | 1 | 2001 | 550 | 0.040 |
Why?
|
Alleles | 1 | 1999 | 284 | 0.040 |
Why?
|
nef Gene Products, Human Immunodeficiency Virus | 1 | 1998 | 51 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2019 | 158 | 0.040 |
Why?
|
env Gene Products, Human Immunodeficiency Virus | 2 | 1994 | 18 | 0.040 |
Why?
|
Influenza, Human | 1 | 1999 | 79 | 0.040 |
Why?
|
Microglia | 2 | 1998 | 152 | 0.040 |
Why?
|
Optic Nerve | 2 | 1995 | 28 | 0.040 |
Why?
|
Pneumonia, Viral | 1 | 1999 | 70 | 0.040 |
Why?
|
Pyrones | 1 | 1996 | 7 | 0.040 |
Why?
|
Specimen Handling | 1 | 2017 | 49 | 0.040 |
Why?
|
Interleukin-1 | 1 | 1996 | 33 | 0.040 |
Why?
|
Animals, Suckling | 2 | 2014 | 10 | 0.040 |
Why?
|
Thailand | 1 | 1996 | 48 | 0.040 |
Why?
|
Philippines | 1 | 2016 | 72 | 0.040 |
Why?
|
Central Nervous System | 2 | 1989 | 130 | 0.040 |
Why?
|
Inclusion Bodies | 2 | 2001 | 33 | 0.040 |
Why?
|
Young Adult | 2 | 2020 | 4012 | 0.040 |
Why?
|
Microwaves | 1 | 1996 | 26 | 0.040 |
Why?
|
Transfection | 2 | 2008 | 496 | 0.030 |
Why?
|
Neuroblastoma | 1 | 1996 | 128 | 0.030 |
Why?
|
Retroviridae | 2 | 1987 | 22 | 0.030 |
Why?
|
Viral Matrix Proteins | 1 | 1995 | 17 | 0.030 |
Why?
|
Blood-Brain Barrier | 2 | 2007 | 153 | 0.030 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 1995 | 42 | 0.030 |
Why?
|
Encephalitis, Viral | 1 | 1995 | 6 | 0.030 |
Why?
|
Brain Neoplasms | 2 | 1998 | 105 | 0.030 |
Why?
|
Singapore | 3 | 1991 | 72 | 0.030 |
Why?
|
History, Medieval | 1 | 1995 | 4 | 0.030 |
Why?
|
History, 16th Century | 1 | 1995 | 4 | 0.030 |
Why?
|
Americas | 1 | 1995 | 6 | 0.030 |
Why?
|
Asia, Southeastern | 1 | 1995 | 11 | 0.030 |
Why?
|
Antigenic Variation | 1 | 1995 | 9 | 0.030 |
Why?
|
Monkey Diseases | 1 | 1995 | 6 | 0.030 |
Why?
|
History, Ancient | 1 | 1995 | 11 | 0.030 |
Why?
|
South America | 1 | 1995 | 16 | 0.030 |
Why?
|
Models, Genetic | 2 | 2006 | 149 | 0.030 |
Why?
|
History, 19th Century | 1 | 1995 | 24 | 0.030 |
Why?
|
Brazil | 1 | 1995 | 66 | 0.030 |
Why?
|
Caribbean Region | 1 | 1995 | 63 | 0.030 |
Why?
|
Iran | 1 | 1995 | 183 | 0.030 |
Why?
|
Aluminum Compounds | 1 | 1994 | 8 | 0.030 |
Why?
|
Retrospective Studies | 1 | 2020 | 1961 | 0.030 |
Why?
|
Conserved Sequence | 1 | 1995 | 106 | 0.030 |
Why?
|
Central Nervous System Viral Diseases | 1 | 2014 | 2 | 0.030 |
Why?
|
Mice, Inbred ICR | 1 | 2014 | 38 | 0.030 |
Why?
|
Chlorides | 1 | 1994 | 52 | 0.030 |
Why?
|
Antibody Formation | 2 | 1992 | 73 | 0.030 |
Why?
|
Histocytochemistry | 3 | 1991 | 45 | 0.030 |
Why?
|
Herpesvirus 6, Human | 1 | 1994 | 4 | 0.030 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2014 | 35 | 0.030 |
Why?
|
Macaca fascicularis | 3 | 1989 | 61 | 0.030 |
Why?
|
Vesicular stomatitis Indiana virus | 1 | 1993 | 7 | 0.030 |
Why?
|
Consensus Sequence | 1 | 1993 | 24 | 0.030 |
Why?
|
Vacuoles | 4 | 1999 | 22 | 0.030 |
Why?
|
Cats | 1 | 1993 | 65 | 0.030 |
Why?
|
Southwestern United States | 1 | 1993 | 35 | 0.030 |
Why?
|
Lepidoptera | 1 | 2013 | 8 | 0.030 |
Why?
|
Nucleotides | 1 | 1993 | 33 | 0.030 |
Why?
|
Seoul virus | 1 | 2013 | 1 | 0.030 |
Why?
|
Carrier State | 1 | 1993 | 32 | 0.030 |
Why?
|
Amyloidosis | 2 | 1991 | 33 | 0.030 |
Why?
|
Hospitals, Teaching | 1 | 2013 | 24 | 0.030 |
Why?
|
Genetic Markers | 1 | 1994 | 118 | 0.030 |
Why?
|
Microscopy, Confocal | 1 | 2014 | 210 | 0.030 |
Why?
|
Brain Diseases | 1 | 1993 | 33 | 0.030 |
Why?
|
Superoxide Dismutase | 1 | 1994 | 149 | 0.030 |
Why?
|
Time Factors | 5 | 2005 | 1681 | 0.030 |
Why?
|
Microtubule-Associated Proteins | 2 | 1991 | 84 | 0.030 |
Why?
|
Sexual Behavior | 1 | 1998 | 587 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 1998 | 438 | 0.030 |
Why?
|
Amino Acids | 1 | 1993 | 139 | 0.030 |
Why?
|
Lymphocytes | 2 | 1999 | 116 | 0.030 |
Why?
|
Base Composition | 1 | 1992 | 22 | 0.030 |
Why?
|
Obesity | 1 | 2020 | 965 | 0.030 |
Why?
|
Depression | 1 | 1999 | 664 | 0.030 |
Why?
|
Repetitive Sequences, Nucleic Acid | 1 | 1992 | 30 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1992 | 45 | 0.030 |
Why?
|
DNA, Single-Stranded | 1 | 1992 | 36 | 0.030 |
Why?
|
Family | 1 | 1993 | 162 | 0.030 |
Why?
|
Mesencephalon | 1 | 1992 | 41 | 0.030 |
Why?
|
Immunocompetence | 2 | 1998 | 8 | 0.030 |
Why?
|
California | 1 | 1993 | 436 | 0.030 |
Why?
|
Astrocytoma | 1 | 1992 | 13 | 0.030 |
Why?
|
Neoplasm Proteins | 1 | 1993 | 203 | 0.030 |
Why?
|
Histocompatibility Testing | 1 | 1991 | 7 | 0.030 |
Why?
|
Cerebral Arteries | 1 | 1991 | 24 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 1991 | 34 | 0.020 |
Why?
|
Atrophy | 1 | 1991 | 40 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 1991 | 19 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 1991 | 58 | 0.020 |
Why?
|
Family Health | 1 | 1990 | 47 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2013 | 366 | 0.020 |
Why?
|
Cerebral Cortex | 1 | 1992 | 274 | 0.020 |
Why?
|
Nasal Mucosa | 2 | 1999 | 29 | 0.020 |
Why?
|
Spinal Cord Diseases | 1 | 1989 | 6 | 0.020 |
Why?
|
Transients and Migrants | 1 | 2010 | 25 | 0.020 |
Why?
|
Visual Pathways | 1 | 1990 | 37 | 0.020 |
Why?
|
Substantia Innominata | 1 | 1989 | 1 | 0.020 |
Why?
|
Peripheral Nervous System Diseases | 1 | 1989 | 26 | 0.020 |
Why?
|
Basal Ganglia | 1 | 1989 | 17 | 0.020 |
Why?
|
Laboratory Infection | 1 | 1988 | 2 | 0.020 |
Why?
|
Amino Acids, Diamino | 1 | 1988 | 3 | 0.020 |
Why?
|
HTLV-II Antibodies | 3 | 1993 | 3 | 0.020 |
Why?
|
Parkinson Disease, Secondary | 1 | 1988 | 9 | 0.020 |
Why?
|
Rats, Inbred Strains | 1 | 1988 | 132 | 0.020 |
Why?
|
Peptides | 1 | 1992 | 308 | 0.020 |
Why?
|
Genetic Techniques | 1 | 2008 | 15 | 0.020 |
Why?
|
Seeds | 1 | 1988 | 34 | 0.020 |
Why?
|
Brain Stem | 1 | 1989 | 46 | 0.020 |
Why?
|
Virus Assembly | 1 | 2008 | 38 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 1993 | 2561 | 0.020 |
Why?
|
Population Surveillance | 1 | 2010 | 231 | 0.020 |
Why?
|
Culture Media | 1 | 2008 | 84 | 0.020 |
Why?
|
Cercopithecidae | 1 | 1988 | 3 | 0.020 |
Why?
|
Cebidae | 1 | 1988 | 4 | 0.020 |
Why?
|
Electron Probe Microanalysis | 1 | 1988 | 10 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 1990 | 229 | 0.020 |
Why?
|
PrP 27-30 Protein | 3 | 1993 | 3 | 0.020 |
Why?
|
Calcium, Dietary | 1 | 1989 | 83 | 0.020 |
Why?
|
Plasmids | 1 | 2008 | 233 | 0.020 |
Why?
|
AIDS-Related Complex | 1 | 1987 | 2 | 0.020 |
Why?
|
Spumavirus | 1 | 1987 | 1 | 0.020 |
Why?
|
Serotonin Antagonists | 1 | 2007 | 22 | 0.020 |
Why?
|
Manganese Poisoning | 2 | 1989 | 11 | 0.020 |
Why?
|
Cattle | 3 | 1993 | 472 | 0.020 |
Why?
|
Magnesium | 2 | 1985 | 95 | 0.020 |
Why?
|
Nerve Fibers, Myelinated | 2 | 2001 | 15 | 0.020 |
Why?
|
Virion | 1 | 1987 | 67 | 0.020 |
Why?
|
Silicon | 1 | 1986 | 16 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 3 | 1993 | 195 | 0.020 |
Why?
|
HIV | 1 | 1987 | 97 | 0.020 |
Why?
|
Microbial Collagenase | 1 | 1986 | 2 | 0.020 |
Why?
|
Apoptosis | 2 | 2008 | 1317 | 0.020 |
Why?
|
Syndrome | 3 | 1998 | 72 | 0.020 |
Why?
|
Terminology as Topic | 1 | 2006 | 32 | 0.020 |
Why?
|
Mitochondria | 2 | 2003 | 454 | 0.020 |
Why?
|
Gerbillinae | 1 | 1985 | 2 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2006 | 196 | 0.020 |
Why?
|
Glioblastoma | 1 | 2005 | 49 | 0.020 |
Why?
|
Green Fluorescent Proteins | 1 | 2006 | 200 | 0.020 |
Why?
|
Neuroglia | 1 | 2005 | 117 | 0.020 |
Why?
|
Immune Tolerance | 1 | 1985 | 61 | 0.020 |
Why?
|
Deltaretrovirus | 1 | 1984 | 1 | 0.020 |
Why?
|
Anopheles | 1 | 2004 | 9 | 0.020 |
Why?
|
Haplotypes | 1 | 2005 | 152 | 0.020 |
Why?
|
Zoology | 1 | 1984 | 1 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 298 | 0.020 |
Why?
|
Databases, Nucleic Acid | 1 | 2004 | 25 | 0.020 |
Why?
|
Genome | 1 | 2005 | 117 | 0.020 |
Why?
|
Aedes | 1 | 2004 | 20 | 0.020 |
Why?
|
Hydroxyproline | 1 | 1984 | 2 | 0.020 |
Why?
|
Sweden | 1 | 1984 | 12 | 0.020 |
Why?
|
Calcitonin | 1 | 1984 | 5 | 0.020 |
Why?
|
Anthropology, Physical | 1 | 1984 | 6 | 0.020 |
Why?
|
Fibroblasts | 1 | 1986 | 252 | 0.020 |
Why?
|
Parathyroid Hormone | 1 | 1984 | 36 | 0.020 |
Why?
|
Nutritional Physiological Phenomena | 1 | 1984 | 35 | 0.010 |
Why?
|
Levodopa | 1 | 1983 | 19 | 0.010 |
Why?
|
Protease Inhibitors | 1 | 2003 | 47 | 0.010 |
Why?
|
Nucleosides | 1 | 2003 | 27 | 0.010 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2003 | 55 | 0.010 |
Why?
|
Skin | 2 | 1986 | 173 | 0.010 |
Why?
|
Colombia | 2 | 1993 | 19 | 0.010 |
Why?
|
Congo Red | 2 | 1993 | 3 | 0.010 |
Why?
|
Phosphorus | 1 | 1984 | 64 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2003 | 217 | 0.010 |
Why?
|
Lactic Acid | 1 | 2003 | 87 | 0.010 |
Why?
|
Membrane Potentials | 1 | 2003 | 213 | 0.010 |
Why?
|
Blood Cells | 1 | 2002 | 8 | 0.010 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2003 | 47 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2002 | 26 | 0.010 |
Why?
|
Adenosine Triphosphate | 1 | 2003 | 180 | 0.010 |
Why?
|
Acute Disease | 1 | 2003 | 141 | 0.010 |
Why?
|
Micronesia | 1 | 1983 | 87 | 0.010 |
Why?
|
Graft vs Host Reaction | 1 | 1982 | 1 | 0.010 |
Why?
|
Exchange Transfusion, Whole Blood | 1 | 1982 | 3 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 1982 | 15 | 0.010 |
Why?
|
Bone Marrow Cells | 1 | 2002 | 75 | 0.010 |
Why?
|
Infant, Newborn, Diseases | 1 | 1982 | 18 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2008 | 874 | 0.010 |
Why?
|
Graft Rejection | 1 | 1982 | 38 | 0.010 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2001 | 10 | 0.010 |
Why?
|
Antigens, Viral, Tumor | 1 | 2001 | 8 | 0.010 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2001 | 8 | 0.010 |
Why?
|
Mice, Inbred BALB C | 2 | 1999 | 649 | 0.010 |
Why?
|
Kidney | 1 | 1984 | 322 | 0.010 |
Why?
|
Amygdala | 1 | 1982 | 110 | 0.010 |
Why?
|
Gene Pool | 1 | 2001 | 2 | 0.010 |
Why?
|
Indians, Central American | 1 | 2001 | 2 | 0.010 |
Why?
|
Point Mutation | 1 | 2001 | 88 | 0.010 |
Why?
|
Amino Acid Substitution | 1 | 2001 | 122 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 1994 | 485 | 0.010 |
Why?
|
Genes, Bacterial | 1 | 2001 | 88 | 0.010 |
Why?
|
Antibodies, Monoclonal | 2 | 1996 | 282 | 0.010 |
Why?
|
HIV Antibodies | 2 | 1993 | 29 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2004 | 901 | 0.010 |
Why?
|
Copper | 1 | 1982 | 101 | 0.010 |
Why?
|
Antibodies, Heterophile | 1 | 1980 | 2 | 0.010 |
Why?
|
Cell Transformation, Viral | 1 | 1980 | 29 | 0.010 |
Why?
|
Mice, Inbred Strains | 2 | 1995 | 117 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2001 | 203 | 0.010 |
Why?
|
Sheep | 1 | 1980 | 70 | 0.010 |
Why?
|
Immunoglobulins | 1 | 1980 | 36 | 0.010 |
Why?
|
Genes, Duplicate | 1 | 2000 | 4 | 0.010 |
Why?
|
Replication Origin | 1 | 2000 | 14 | 0.010 |
Why?
|
Tissue Preservation | 1 | 1980 | 7 | 0.010 |
Why?
|
Polyarteritis Nodosa | 1 | 1980 | 4 | 0.010 |
Why?
|
Population Dynamics | 1 | 2000 | 29 | 0.010 |
Why?
|
Mast Cells | 1 | 2001 | 77 | 0.010 |
Why?
|
Lymph Nodes | 1 | 1980 | 67 | 0.010 |
Why?
|
Cardiovascular System | 1 | 1980 | 30 | 0.010 |
Why?
|
Thymus Gland | 1 | 1980 | 77 | 0.010 |
Why?
|
Dendrites | 2 | 1989 | 52 | 0.010 |
Why?
|
Terminal Repeat Sequences | 1 | 1999 | 8 | 0.010 |
Why?
|
Gene Deletion | 1 | 2000 | 156 | 0.010 |
Why?
|
Lipofuscin | 1 | 1999 | 4 | 0.010 |
Why?
|
Chile | 1 | 1999 | 6 | 0.010 |
Why?
|
Quality of Life | 1 | 1983 | 459 | 0.010 |
Why?
|
Myofibrils | 1 | 1999 | 7 | 0.010 |
Why?
|
Glycogen | 1 | 1999 | 17 | 0.010 |
Why?
|
Death | 1 | 1999 | 8 | 0.010 |
Why?
|
Staining and Labeling | 2 | 1991 | 100 | 0.010 |
Why?
|
Chick Embryo | 1 | 1999 | 71 | 0.010 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 1998 | 12 | 0.010 |
Why?
|
Temporal Lobe | 1 | 1998 | 22 | 0.010 |
Why?
|
Administration, Intranasal | 1 | 1999 | 77 | 0.010 |
Why?
|
Cerebral Amyloid Angiopathy | 1 | 1998 | 17 | 0.010 |
Why?
|
Fatal Outcome | 1 | 1998 | 38 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 522 | 0.010 |
Why?
|
Survival Analysis | 1 | 1999 | 322 | 0.010 |
Why?
|
Antigen Presentation | 1 | 1998 | 54 | 0.010 |
Why?
|
Phagocytosis | 1 | 1998 | 64 | 0.010 |
Why?
|
Apolipoproteins E | 1 | 1998 | 129 | 0.010 |
Why?
|
Cytoplasm | 2 | 1992 | 135 | 0.010 |
Why?
|
tau Proteins | 1 | 1998 | 161 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 1996 | 55 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 2001 | 520 | 0.010 |
Why?
|
Molecular Weight | 2 | 1994 | 161 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 1996 | 91 | 0.010 |
Why?
|
Radiography | 2 | 1989 | 75 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1996 | 139 | 0.010 |
Why?
|
Histological Techniques | 1 | 1996 | 14 | 0.010 |
Why?
|
Chronic Disease | 2 | 1991 | 469 | 0.010 |
Why?
|
Cohort Studies | 1 | 2000 | 1422 | 0.010 |
Why?
|
Indians, North American | 1 | 1997 | 145 | 0.010 |
Why?
|
Regression Analysis | 2 | 1989 | 429 | 0.010 |
Why?
|
Radioimmunoprecipitation Assay | 1 | 1995 | 1 | 0.010 |
Why?
|
Deoxyribonucleases, Type II Site-Specific | 1 | 1995 | 8 | 0.010 |
Why?
|
Papio | 1 | 1995 | 21 | 0.010 |
Why?
|
Macaca | 1 | 1995 | 38 | 0.010 |
Why?
|
Exanthema Subitum | 1 | 1994 | 1 | 0.010 |
Why?
|
Inflammation | 1 | 1999 | 577 | 0.010 |
Why?
|
Slovakia | 1 | 1994 | 7 | 0.010 |
Why?
|
Giant Cells | 1 | 1994 | 13 | 0.010 |
Why?
|
HIV-2 | 1 | 1993 | 8 | 0.010 |
Why?
|
Up-Regulation | 1 | 1996 | 490 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 1994 | 89 | 0.010 |
Why?
|
Gene Expression | 1 | 1997 | 639 | 0.010 |
Why?
|
Mink | 1 | 1993 | 1 | 0.010 |
Why?
|
Birefringence | 1 | 1993 | 2 | 0.010 |
Why?
|
Saimiri | 1 | 1993 | 6 | 0.010 |
Why?
|
Fetal Blood | 1 | 1993 | 47 | 0.010 |
Why?
|
Thymidine | 1 | 1993 | 15 | 0.010 |
Why?
|
Tritium | 1 | 1993 | 48 | 0.010 |
Why?
|
Ferrets | 1 | 1993 | 12 | 0.010 |
Why?
|
Contact Tracing | 1 | 1993 | 17 | 0.010 |
Why?
|
Genes, Regulator | 1 | 1993 | 25 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 1993 | 3 | 0.010 |
Why?
|
L-Lactate Dehydrogenase | 1 | 1993 | 59 | 0.010 |
Why?
|
Open Reading Frames | 1 | 1993 | 73 | 0.010 |
Why?
|
Haplorhini | 2 | 1984 | 21 | 0.010 |
Why?
|
Gene Products, rex | 1 | 1992 | 1 | 0.010 |
Why?
|
Immunoblotting | 1 | 1993 | 170 | 0.010 |
Why?
|
Glioma | 1 | 1993 | 76 | 0.010 |
Why?
|
Cell Division | 1 | 1993 | 296 | 0.010 |
Why?
|
DNA Replication | 1 | 1993 | 148 | 0.010 |
Why?
|
Cell Death | 1 | 1993 | 260 | 0.010 |
Why?
|
Ribosomes | 1 | 1992 | 27 | 0.010 |
Why?
|
Evaluation Studies as Topic | 1 | 1992 | 51 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1991 | 21 | 0.010 |
Why?
|
Kinetics | 1 | 1993 | 650 | 0.010 |
Why?
|
Nucleic Acid Conformation | 1 | 1992 | 142 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1994 | 984 | 0.010 |
Why?
|
Lethal Dose 50 | 1 | 1991 | 30 | 0.010 |
Why?
|
Alcian Blue | 1 | 1991 | 3 | 0.010 |
Why?
|
Hospitals, General | 1 | 1991 | 7 | 0.010 |
Why?
|
Immune Sera | 1 | 1991 | 59 | 0.010 |
Why?
|
Organelles | 1 | 1991 | 23 | 0.010 |
Why?
|
Down Syndrome | 1 | 1991 | 29 | 0.010 |
Why?
|
Equipment Contamination | 1 | 1990 | 5 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1993 | 287 | 0.010 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1993 | 406 | 0.010 |
Why?
|
Protein Conformation | 1 | 1991 | 350 | 0.010 |
Why?
|
Anterior Chamber | 1 | 1990 | 11 | 0.010 |
Why?
|
Animals, Newborn | 1 | 1991 | 323 | 0.010 |
Why?
|
Synaptic Vesicles | 1 | 1989 | 29 | 0.010 |
Why?
|
Visual Cortex | 1 | 1990 | 58 | 0.010 |
Why?
|
Heart | 1 | 1991 | 178 | 0.010 |
Why?
|
Intermediate Filament Proteins | 1 | 1989 | 14 | 0.010 |
Why?
|
Oxidoreductases | 1 | 1969 | 82 | 0.010 |
Why?
|
Intermediate Filaments | 1 | 1989 | 18 | 0.010 |
Why?
|
Cell Count | 1 | 1989 | 129 | 0.010 |
Why?
|
Models, Biological | 1 | 1992 | 642 | 0.010 |
Why?
|
Synapses | 1 | 1990 | 173 | 0.010 |
Why?
|
Paraplegia | 1 | 1988 | 2 | 0.010 |
Why?
|
Tropical Climate | 1 | 1988 | 21 | 0.010 |
Why?
|
Disease Outbreaks | 1 | 1989 | 155 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1989 | 528 | 0.000 |
Why?
|
HIV Antigens | 1 | 1987 | 5 | 0.000 |
Why?
|
Flavonoids | 1 | 1988 | 78 | 0.000 |
Why?
|
Virus Cultivation | 1 | 1987 | 5 | 0.000 |
Why?
|
Longitudinal Studies | 1 | 1989 | 841 | 0.000 |
Why?
|
Disease Susceptibility | 1 | 1987 | 92 | 0.000 |
Why?
|
Bacteria | 1 | 1969 | 245 | 0.000 |
Why?
|
Phenylmercuric Acetate | 1 | 1986 | 2 | 0.000 |
Why?
|
Antigen-Antibody Complex | 1 | 1986 | 19 | 0.000 |
Why?
|
Pancreas | 1 | 1986 | 32 | 0.000 |
Why?
|
Organ Culture Techniques | 1 | 1986 | 99 | 0.000 |
Why?
|
Immunization, Passive | 1 | 1985 | 18 | 0.000 |
Why?
|
Rats, Inbred F344 | 1 | 1986 | 228 | 0.000 |
Why?
|
Immunoglobulin M | 1 | 1985 | 81 | 0.000 |
Why?
|
Enzyme Activation | 1 | 1986 | 423 | 0.000 |
Why?
|
Immunity, Cellular | 1 | 1985 | 68 | 0.000 |
Why?
|
Spleen | 1 | 1985 | 192 | 0.000 |
Why?
|
Mice, Nude | 1 | 1985 | 323 | 0.000 |
Why?
|
Cytoskeleton | 1 | 1984 | 98 | 0.000 |
Why?
|
Sclerosis | 1 | 1982 | 6 | 0.000 |
Why?
|
Spectrometry, X-Ray Emission | 1 | 1982 | 17 | 0.000 |
Why?
|
Blood Group Incompatibility | 1 | 1982 | 1 | 0.000 |
Why?
|
Jaundice, Neonatal | 1 | 1982 | 1 | 0.000 |
Why?
|
Transplantation Immunology | 1 | 1982 | 5 | 0.000 |
Why?
|
ABO Blood-Group System | 1 | 1982 | 5 | 0.000 |
Why?
|
Rh-Hr Blood-Group System | 1 | 1982 | 4 | 0.000 |
Why?
|
Diet | 1 | 1989 | 747 | 0.000 |
Why?
|
Hypothalamus | 1 | 1982 | 122 | 0.000 |
Why?
|
Injections | 1 | 1980 | 35 | 0.000 |
Why?
|
Freezing | 1 | 1980 | 15 | 0.000 |
Why?
|
Cell Nucleus | 1 | 1982 | 351 | 0.000 |
Why?
|
Herpesvirus 3, Human | 1 | 1980 | 12 | 0.000 |
Why?
|
Aging | 1 | 1985 | 639 | 0.000 |
Why?
|
Pregnancy | 1 | 1985 | 1503 | 0.000 |
Why?
|
Cell Membrane | 1 | 1980 | 360 | 0.000 |
Why?
|
Azotobacter | 1 | 1969 | 2 | 0.000 |
Why?
|
Proteus | 1 | 1969 | 2 | 0.000 |
Why?
|
Desulfovibrio | 1 | 1969 | 2 | 0.000 |
Why?
|
Methods | 1 | 1969 | 12 | 0.000 |
Why?
|
Manometry | 1 | 1969 | 7 | 0.000 |
Why?
|
Chemistry | 1 | 1969 | 17 | 0.000 |
Why?
|
Centrifugation, Density Gradient | 1 | 1969 | 22 | 0.000 |
Why?
|
Clostridium | 1 | 1969 | 19 | 0.000 |
Why?
|
Chromatography, Gel | 1 | 1969 | 46 | 0.000 |
Why?
|
Chemical Phenomena | 1 | 1969 | 53 | 0.000 |
Why?
|
Solubility | 1 | 1969 | 115 | 0.000 |
Why?
|